Skip to content


Xyrem (oxybate) is a small molecule pharmaceutical. Oxybate was first approved as Xyrem on 2002-07-17. It is used to treat cataplexy in the USA. It has been approved in Europe to treat cataplexy and narcolepsy. It is known to target hydroxycarboxylic acid receptor 1. Xyrem's patents are valid until 2033-03-15 (FDA).
Trade Name Xyrem
Common Name Oxybate
Indication cataplexy, narcolepsy
Drug Class
Get full access now